Latest News

CLINICAL CASES IN MS – CASE 6: DIAGNOSTIC DILEMMA

 

Click here to watch Dr. Virender Bhan discuss the case and the responses to the survey.

Joseph is a 28-year-old shipping manager at a local warehouse. He is married and has a three-year-old daughter. He presents in April 2021 following an episode of right sided vision loss, with minimal pain. Exam showed visual acuity 20/400, loss of colour vision and an afferent pupillary defect. The rest of his neuro exam is normal. Brain MRI revealed MS-like white-matter abnormalities with a moderate burden of disease and evidence of right optic neuritis (T2 hyperintensity and contrast enhancement). He was treated with IVMP 1000 mg daily x 3 days, with minimal improvement. There is no history of comorbid conditions and no family history of demyelinating or autoimmune disorders. He has not received a COVID-19 vaccine. Extensive discussion does not change his mind and he says he has no plans to get vaccinated. Read More

Is a cell-depleting DMT safe prior to HSCT?

 

Long-acting disease-modifying therapies do not appear to increase the risk of complications following autologous hematopoietic stem cell transplantation (aHSCT), according to a retrospective study from Sweden (Kvistad et al. J Neurol Neurosurg Psychiatry 2022;93:844-848). Read More

TOPICS:

COVID update: the 7th wave

 

Ontario and Quebec have announced that they are now seeing a seventh wave of COVID-19 infections, although case numbers are uncertain due to a lack of reporting. Health Canada reports 21,317 new cases for the week ending July 8, but acknowledges that this is an underestimate (https://health-infobase.canada.ca/src/data/covidLive/Epidemiological-summary-of-COVID-19-cases-in-Canada-Canada.ca.pdf). The Northwest Territories and Nunavut no longer publish COVID case numbers while Saskatchewan posts case numbers only once a month. Read More